Pulmonary Tuberculosis in a Child Receiving Intensive Chemotherapy for Acute Myeloblastic Leukemia

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 1, 2004, Pages 64-67

  Klossek, Antje ^a   Dannenberg, Claudia ^a   Feuerhahn, Mario Rodriguez ^a   Körholz, Dieter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Acute myeloblastic leukemia; Chemotherapy; Childhood; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYTARABINE; ETOPOSIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TIOGUANINE;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BACTERIUM CULTURE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG TOLERABILITY; HUMAN; LEUKEMIA REMISSION; LIVER TOXICITY; LUNG INFILTRATE; LUNG TUBERCULOSIS; MALE; OPEN LUNG BIOPSY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTITUBERCULAR AGENTS; CHILD; DISEASE-FREE SURVIVAL; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; REMISSION INDUCTION; TUBERCULOSIS, PULMONARY;

EID: 0346373797     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200401000-00019     Document Type: Article

References (24)

1. Kaatsch P. Annual report 2002, German Childhood Cancer Registry. Mainz: Druckerei Lindner OHG, 2002.
2. Creutzig U, Ritter J, Zimmermann M, et al. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. J Clin Oncol. 2001;19:2705-2713.
3. Menon BS, Maziah WM, Aiyar S, et al. Disseminated tuberculosis in acute leukemia. Pediatr Intl. 2001;43:161-163.
4. Waecker NJ, Stefanova R, Cave MD, et al. Nosocomial transmission of Mycobacterium bovis bacille Calmette-Guerin to children receiving cancer therapy and to their health care providers. Clin Infect Dis. 2000;30:356-362.
5. Aljurf M, Gyger M, Alrajhi A, et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant. 1999;24:551-554.
6. Weiser MA, O'Brien S, Escalante C, et al. Tuberculosis meningitis in a patient with acute myclogenous leukemia. Leuk Lymphoma. 1999;33:187-192.
7. Lee DG, Choi JH, Kim YJ, et al. Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia. Int J Hematol. 2001;73:119-121.
8. Jagarlamundi R, Kumar L, Kochupillai V, et al. Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol. 2000;17:111-116.
9. Datta M, Swaminathan S. Global aspects of tuberculosis in children. Pediatr Resp Rev. 2001;2:91-96.
10. Pomputius WF 3rd, Rost J, Dennehy PH, et al. Standardization of gastric aspirate technique improves yield in the diagnosis of tuberculosis in children. Pediatr Infect Dis J. 1997;16:222-226.
11. Neu N, Saiman L, San Gabriel P, et al. Diagnosis of pediatric tuberculosis in the modern era. Pediatr Infect Dis J. 1999;18:122-126.
12. Delacourt C, Mani TM, Bonnerot V, et al. Computed tomography with normal chest radiograph in tuberculous infection. Arch Dis Child. 1993;69:430-432.
13. Gomez-Pastrana D, Torronteras R, Caro P, et al. Diagnosis of tuberculosis in children using a polymerase chain reaction. Pediatr Pulmonol. 1999;28:344-351.
14. Delacourt C, Poveda JD, Chureau C, et al. Use of polymerase chain reaction for improved diagnosis of tuberculosis in children. J Pediatr. 1995;126:703-709.
15. Pierre C, Olivier C, Lecossier D, et al. Diagnosis of primary tuberculosis in children by amplification and detection of mycobacteria DNA. Am Rev Respir Dis. 1993;147:420-424.
16. De Charnace G, Delacourt C. Diagnosic techniques in pediatric tuberculosis. Pediatr Resp Rev. 2001;2:120-125.
17. Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472-1477.
18. Teleman MD, Chee CB, Earnest A, et al. Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore. Int J Tuberc Lung Dis. 2002;6:699-705.
19. Duirand F, Jebrak G, Pessayre D, et al. Hepatoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf. 1996;15:394-405.
20. Ortiz de Saracho J, Pantoja Zarza L, Smucler A. Toxic neutropenia due to antituberculosis drug therapy. Arch Bronchopneumologia. 2000;36:230-231.
21. Van Assendelft AH. Leucopenia in rifampicin chemotherapy. J Antimicrob Chemother. 1985;16:407-408.
22. Burghouts J, Haanen C. A possible role of rifampicin in prolonging remission duration in acute myelogenous leukaemia. Scand J Haematol. 1986;36:376-378.
23. Liu RS, Yao EG, Nie YL. Treatment of acute leukemia with rifampin and low-dose harringtonine. Analysis of 14 cases. Chin Med J (Engl). 1989;102:695-697.
24. Su WJ, Huang CY, Huang CY, et al. Utility of PCR assays for rapid diagnosis of BCG infection in children. Int J Tuberc Lung Dis. 2001;5:380-384.